Smart Messages and Alerts for an Infusion Delivery and Management System

• US 20110275920A1
• Filed: 07/18/2011
• Published: 11/10/2011
• Est. Priority Date: 02/28/2006
• Status: Active Grant

• Current Assignee: Abbott Diabetes Care Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Abbott Diabetes Care Incorporated (Abbott Laboratories Incorporated)
• Inventors: Krapek, Kimberly A., Jennewine, R. Curtis
• Granted Patent: US 9,782,076 B2
• Time in Patent Office: Days
• US Class Current: 600/365
• CPC Class Codes: A61B 5/0031 Implanted circuitry
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/4839 combined with drug delivery
• CPC Class Codes: G16H 20/17 delivered via infusion or injection
• CPC Class Codes: G16H 40/67 for remote operation
• CPC Class Codes: G16H 50/30 for calculating health indices; for individual health risk assessment

Abstract

Method and system for providing diabetes management is provided.

Claims

1. A method of managing hypoglycemia, comprising:

programming a pre-sleep mode with an interface device, wherein the pre-sleep mode includes a pre-sleep time period prior to when a patient enters a sleep cycle;

detecting the pre-sleep mode with the interface device;

comparing, using a processor, one or more of a predetermined number of consecutive analyte related levels for the pre-sleep time period to a predetermined target level; and

generating, using the processor, an alert when one or more of the predetermined number of consecutive analyte related levels deviates from the predetermined target level.

2. The method of claim 1 further including measuring an analyte level of a patient to determine the one or more of the predetermined number of consecutive analyte related levels.

3. The method of claim 2 wherein the measuring the analyte level includes using one or more of a discrete blood glucose meter or a continuous analyte monitoring system.

4. The method of claim 1 further including outputting the alert on the medication delivery unit.

5. The method of claim 1 wherein the predetermined target level includes a target upper or lower analyte level.

6. The method of claim 5 wherein the alert is generated when one or more of the predetermined number of analyte related levels reaches the target upper or lower analyte level.

7. The method of claim 1 wherein the alert includes one or more of an audible alert, a visual alert, or a tactile alert.

8. The method of claim 7 wherein the visual alert includes one or more of an alphanumeric output display, a graphical output display, an icon display, a video output display, a color display or an illumination display.

9. The method of claim 1 further including outputting the generated alert.

10. The method of claim 1 wherein the pre-sleep time period begins at approximately a predetermined number of hours after the last meal of the day, and terminates at the beginning of entering the sleep cycle.

11. The method of claim 1 wherein generating the alert includes generating a treatment recommendation.

12. A system for managing hypoglycemia, comprising:

a processor unit configured to perform data processing based on one or more analyte related data, the processor unit further configured to generate one or more of an alert or a notification for output;

wherein the processor unit is configured to program a pre-sleep mode including a pre-sleep time period prior to when a patient enters a sleep cycle, to detect the pre-sleep mode, to compare the one or more analyte related data for the pre-sleep time period to one or more predetermined target analyte levels, and to generate the one or more of the alert or the notification for one or more of an audible output, visual output or a tactile output.

13. The system of claim 12 further including an input unit and an output unit operatively coupled to the processor unit, the input unit configured to receive the one or more analyte related data, and the output unit configured to output the one or more of the alert or the notification.

14. The system of claim 12 wherein the processor unit is configured to receive substantially in real time, a plurality of analyte levels of a patient.

15. The system of claim 12 wherein the processor unit is operatively coupled to a housing of an infusion device.

16. The system of claim 15 wherein the infusion device includes an insulin pump.

17. A system for managing hypoglycemia, comprising:

an analyte monitoring system configured to monitor an analyte level of a patient substantially in real time;

a medication delivery unit operatively coupled to the analyte monitoring system for wirelessly receiving data associated with the monitored analyte level of the patient substantially in real time from the analyte monitoring system; and

a data processing unit operatively coupled to one or more of the analyte monitoring system or the medication delivery unit, the data processing unit configured to program a pre-sleep mode, wherein the pre-sleep mode includes a pre-sleep time period prior to when a patient enters a sleep cycle, to compare one or more of a predetermined number of consecutive monitored analyte levels during the pre-sleep time period to a predetermined target level, and to output one or more of an alert or notification corresponding to the monitored analyte levels.

18. The system of claim 17 wherein the analyte monitoring system is configured to wirelessly communicate with the medication delivery unit over a radio frequency (RF) communication link, a Bluetooth communication link, an Infrared communication link, or a local area network (LAN).

19. The system of claim 17 wherein the data processing unit is configured to generate and output an alert when one or more of the predetermined number of consecutive monitored analyte related levels reaches the predetermined target level.